Compare and Contrast: As Glucagon-Like Peptide-1 Receptor Agonist Access Expands, Comparative Heart Outcomes Matter

As the onslaught of anti-obesity drugs hit the market in recent years, more research is being released about their potential side effects as well as their benefits. Endocrine News investigates two of these studies to gain more insight to how these “miracle drugs” could affect cardiac health. Two studies published in late 2025 examined cardiovascular […]

To view the full Member Resource, please Log in


TOPICS IN THIS ARTICLE:

Share this article